Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Maternal cannabis use may expose infants to harmful compounds through breast milk (opens in a new tab)

medicalxpress.com · 2026-10-16

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 2 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of four checks out. Two claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4OverstatedInfants whose mothers smoked cannabis while breastfeeding had volatile organic compounds in their urine, a recent study shows.View evidenceHide evidence

As statedvolatile organic compounds in their urine

Why this verdict

The abstract-level profile supports the central finding that infants of cannabis-using, breastfeeding mothers had detectable urinary VOC metabolites. However, the headline wording outruns the more precise body/paper evidence by saying infants had volatile organic compounds themselves in urine rather than VOC metabolites, and by framing the exposure as mothers who 'smoked' cannabis when the paper profile includes cannabis use by smoking and/or vaping.

1

Study evidence

Infant urine samples contained detectable levels of 24 VOC metabolites.

“Twenty mother-infant dyads (<6 months postpartum) living in Washington and Oregon were enrolled in the Lactation and Cannabis (LAC) Study, and nineteen were included in the current study.”
Claim 2 of 4Not coveredThe study was conducted at Washington State University and published in the International Journal of Environmental Research and Public Health, and the article says it is the first to investigate whether infants breastfed by women using cannabis show evidence of exposure to VOCs.View evidenceHide evidence

As statedthe first to investigate

Why this verdict

The paper profile supports that the study investigated whether breastfed infants of mothers using cannabis had detectable urinary VOC metabolites. But the supplied abstract-depth profile does not verify the Washington State University attribution, the journal publication venue, or the stronger 'first to investigate' claim.

1

Study evidence

Infant urine samples contained detectable levels of 24 VOC metabolites.

“Twenty mother-infant dyads (<6 months postpartum) living in Washington and Oregon were enrolled in the Lactation and Cannabis (LAC) Study, and nineteen were included in the current study.”
Claim 3 of 4Not coveredThe study enrolled breastfeeding women in Washington or Oregon who reported smoking or vaping cannabis more than once a week, collected milk and infant urine samples before and after cannabis use, and found detectable levels of 24 VOC metabolites across the urine samples, with all infants having at least one detectable sample and higher concentrations after cannabis use than at baseline.View evidenceHide evidence

As stated24 VOC metabolites

Why this verdict

Several core details are supported by the abstract profile: Washington/Oregon dyads, baseline and post-use milk/urine sampling, 24 detectable urinary VOC metabolites, and higher post-use concentrations for 15 metabolites versus matched baseline samples. But the supplied profile does not verify the eligibility detail that mothers reported smoking or vaping more than once a week or that every infant had at least one detectable sample. The claim also compresses the post-use increase without specifying that it applied to 15 metabolites, not necessarily all 24.

1

Study evidence

Infant urine samples contained detectable levels of 24 VOC metabolites.

“Twenty mother-infant dyads (<6 months postpartum) living in Washington and Oregon were enrolled in the Lactation and Cannabis (LAC) Study, and nineteen were included in the current study.”
Claim 4 of 4SupportedThe article says the finding suggests a potential VOC exposure pathway for infants, but the researcher emphasized that the concentrations may not be high enough to affect infant health and that more research is needed on health risks and long-term outcomes.View evidenceHide evidence

Why this verdict

This is consistent with the abstract-level profile: the authors interpret the findings as measurable infant VOC exposure associated with maternal cannabis use, and the profile states that further research is needed to assess potential health implications. The story’s caveat that health impact is unknown is aligned with the paper profile’s stated need for more research rather than a demonstrated health-risk claim.

1

Study evidence

Infant urine samples contained detectable levels of 24 VOC metabolites.

“Twenty mother-infant dyads (<6 months postpartum) living in Washington and Oregon were enrolled in the Lactation and Cannabis (LAC) Study, and nineteen were included in the current study.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Population details: the analyzed cohort was small, with 19 included mother–infant dyads, infants under 6 months postpartum, and exclusively breastfed infants.

    The story mentions breastfeeding women and geography, but the caveats presented do not include the small sample size or the exclusive-breastfeeding and infant-age restrictions that affect generalizability.

    From prospective repeated-measures observational sampling of mother–infant dyads

  • Secondary finding: urinary 2CyEMA and 2CaEMA were positively correlated with Δ9-THC concentrations in maternal milk.

    The story focuses on detectable VOC metabolites and post-use increases but does not report the milk-THC correlation findings for specific metabolites.

    From Observational biospecimen-linked analysis (mother–infant dyads)

  • Secondary modality finding: infant urinary 2CyEMA and 2CaEMA concentrations differed by maternal cannabis use modality, with higher concentrations reported for smoking-related categories compared with exclusive vaping.

    The story notes smoking or vaping as enrollment/use context but does not cover the paper’s reported smoking-versus-vaping regression comparisons.

    From observational dyad study with self-reported modality

  • Limitation: observational design and possible unmeasured confounding, including other environmental VOC sources, limit causal attribution to maternal cannabis use alone.

    The story frames the pathway cautiously, but the listed caveats do not mention observational confounding or alternative VOC sources, which are interpretation-changing limitations in the abstract profile.

    From prospective repeated-measures observational sampling of mother–infant dyads

  • Limitation: multiple metabolites were tested and the abstract profile does not report multiple-comparison correction or full assay/model details.

    The story’s caveats do not discuss multiple testing, limited model details, or assay-detail limitations from the abstract-level profile.

    From prospective repeated-measures observational sampling of mother–infant dyads; observational dyad study with self-reported

4 things the story did carry across
  • Primary study design: a human observational repeated-measures biomonitoring study of mother–infant dyads, with baseline urine/milk after at least 12 hours of abstention and post-cannabis-use sampling over 8–12 hours.
  • Main empirical finding: infant urine samples had detectable levels of 24 VOC metabolites, and post-use samples showed higher concentrations for 15 metabolites compared with matched baseline samples.
  • Interpretation caveat: the findings show exposure/association, not demonstrated infant health harm, and further research is needed on health implications.
  • Limitation: the sampling window captured short-term 8–12 hour post-use changes and does not assess longer-term exposure patterns or outcomes.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoDetermine whether exclusively breastfed infants of mothers who use cannabis have detectable urinary volatile organic compound (VOC) metabolites, and whether these metabolites change after maternal cannabis use compared with a baseline abstention sample.prospective repeated-measures observational sampling of mother–infant dyadsExpand

In plain English

Prospective repeated-measures biomonitoring of exclusively breastfed infants (19 mother–infant dyads, <6 months postpartum) found detectable urinary metabolites of volatile organic compounds (24 distinct VOC metabolites). Infant urine collected after maternal cannabis use (three post-use samples over 8–12 h) showed higher concentrations for 15 VOC metabolites compared with matched baseline samples collected after ≥12 h maternal abstention (p < 0.05). Urinary concentrations of two specific metabolites (2CyEMA, an acrylonitrile metabolite; and 2CaEMA, an acrylamide metabolite) were positively correlated with ∆9-THC concentrations measured in maternal milk. Reported regression coefficients comparing maternal use modality indicated differences in infant urinary metabolite concentrations by smoking versus vaping: for 2CyEMA, B = -0.637, SE = 0.317, p = 0.044; for 2CaEMA, B = -4.06, SE = 1.42, p = 0.004. Overall, results indicate measurable VOC exposure in infants of mothers who use cannabis in this cohort.

Key findings

  • Infant urine samples contained detectable levels of 24 VOC metabolites.
  • Non-baseline infant urine (post maternal cannabis use) had greater concentrations of 15 VOC metabolites compared with matched baseline samples.15 metabolites showed higher concentrations post-use (reported p < 0.05)
“Twenty mother-infant dyads (<6 months postpartum) living in Washington and Oregon were enrolled in the Lactation and Cannabis (LAC) Study, and nineteen were included in the current study.”
What this piece can’t prove
  • Small sample size (19 mother–infant dyads included) limits precision and generalizability.
  • Sampling captures short-term (8–12 h post-use) changes and a baseline after ≥12 h abstention; longer-term exposure patterns are not assessed.
  • Analytical platform and full assay details for urinary VOC metabolite measurement are not specified in the provided abstract.
  • Multiple metabolites tested; abstract does not report corrections for multiple comparisons.

1 further detail could not be confirmed from the summary.

2human in vivoAssess relationships between infant urinary VOC metabolite concentrations and (a) milk Δ9-THC concentrations and (b) maternal cannabis use modality (smoking vs vaping).Observational biospecimen-linked analysis (mother–infant dyads)Expand

In plain English

In an observational analysis of mother–infant dyads (19 dyads included), investigators examined whether infant urinary concentrations of volatile organic compound (VOC) metabolites were associated with milk Δ9-tetrahydrocannabinol (Δ9-THC) concentrations and with maternal cannabis use modality (smoking versus vaping). Urinary 2CyEMA (acrylonitrile metabolite) and 2CaEMA (acrylamide metabolite) were reported to be positively correlated with milk Δ9-THC. Regression results reported differences in infant urinary metabolite concentrations by maternal modality: 2CyEMA and 2CaEMA differed between infants of mothers who smoked (including smoked+vaped or any smoking) versus those whose mothers exclusively vaped on the study day.

Key findings

  • Urinary 2CyEMA (acrylonitrile metabolite) concentrations were positively correlated with milk Δ9-THC concentrations.
  • Urinary 2CaEMA (acrylamide metabolite) concentrations were positively correlated with milk Δ9-THC concentrations.
“111 milk samples were previously analyzed for ∆9-THC.”
3human in vivoAssess relationships between infant urinary VOC metabolite concentrations and (a) milk Δ9-THC concentrations and (b) maternal cannabis use modality (smoking vs vaping).observational dyad study with self-reported modalityExpand

In plain English

In an observational study of 19 mother–infant dyads, regression comparisons by maternal cannabis use modality (smoking including mixed smoking+vaping vs exclusive vaping) reported higher infant urinary concentrations of two VOC metabolites (2CyEMA and 2CaEMA) in infants of mothers who smoked versus those whose mothers only vaped; effect estimates and p-values are reported in the abstract.

Key findings

  • Urinary 2CyEMA concentrations were higher in infants whose mothers primarily smoked (including those who smoked and vaped) compared to those who exclusively vaped.B = -0.637, SE = 0.317, p = 0.044
  • Urinary 2CaEMA concentrations were greater in the urine produced by infants whose mothers reported any cannabis smoking versus only vaping on the study day.B = -4.06, SE = 1.42, p = 0.004
“Relationships between infant urinary VOC metabolite concentrations and milk delta-9-tetrahydrocannabinol (∆9-THC) concentrations and cannabis use modality (smoking/vaping) were documented.”
What this piece can’t prove
  • Small sample size (19 dyads included) and limited geographic sampling (Washington and Oregon).
  • Maternal modality was self-reported; modality categories included mixed-use groups (e.g., smoked and vaped) which may complicate interpretation of contrasts.
  • Abstract does not report model covariates, adjustment for potential confounders, or multiple-comparison considerations.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Volatile Organic Compound Metabolites Are Found in the Urine of Breastfed Infants Whose Mothers Use Cannabis: The Lactation and Cannabis (LAC) Study

International journal of environmental research and public health · 2026

Deep dive in Tessa (opens in a new tab)Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

SelectedOpen access

Volatile Organic Compound Metabolites Are Found in the Urine of Breastfed Infants Whose Mothers Use Cannabis: The Lactation and Cannabis (LAC) Study

International Journal of Environmental Research and Public Health · 2026 · PubMed, Europe PMC, Crossref

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

From Hive to Health: A Regional Occupational Health Needs Assessment of Beekeepers

International Journal of Environmental Research and Public Health · 2026 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.